“…Macrophages, along with other inflammatory cell types, provide a wide range of bioactive molecules that cause marked changes in the inflammatory loci by interacting with epithelial, mesenchymal and vascular endothelial cells. For example, genistein quercetin, luteolin and luteolin-7-glucoside were found to prevent IL-6, IL-1β, and TNF- α formation in LPS-induced human monocytes, as in macrophages, gastric epithelial cells, and osteoblasts while eriodictyol and hesperetin only inhibited TNF-α release [ 69 , 114 , 151 , 152 , 153 , 154 , 155 , 156 , 157 ].…”